Koren G, Klein J, Giesbrecht E, Ben Dayan R, Soldin S, Sellers E, MacLeod S, Silverman M
Division of Clinical Pharmacology, Hospital for Sick Children, Ontario, Canada.
J Pharmacol Exp Ther. 1988 Dec;247(3):1193-8.
Quinidine is known to inhibit the renal clearance of digoxin without affecting glomerular filtration rate. The renal interaction between these drugs was investigated by a combination of in vivo and in vitro methods. The uptake of digoxin by brush border membrane vesicles was not affected by quinidine. Similarly, digoxin did not inhibit the uptake of the cation N-methylnicotinamide by these vesicles and did not alter the binding kinetics of digoxin to the Na+, K+-adenosine triphosphatase by the antiluminal membrane vesicles. By using the in vivo multiple indicator dilution technique transtubular transport of digoxin was documented; renal-artery infusion of quinidine did not affect the recovery of digoxin in the renal vein or urine. Clearance studies documented that the decrease in the renal clearance of digoxin is paralleled by a significant fall in renal blood flow evidenced by a decrease in p-aminohippuric acid clearance. It is concluded that quinidine inhibits the renal excretion of digoxin not by competition at the tubular cell membrane level, but rather by decreasing renal blood flow. A parallel decrease in biliary clearance of digoxin is documented and may suggest a similar mechanism.
已知奎尼丁可抑制地高辛的肾脏清除率,而不影响肾小球滤过率。通过体内和体外方法相结合,研究了这些药物之间的肾脏相互作用。奎尼丁不影响刷状缘膜囊泡对地高辛的摄取。同样,地高辛不抑制这些囊泡对阳离子N-甲基烟酰胺的摄取,也不改变地高辛与抗腔面膜囊泡中钠钾-三磷酸腺苷酶的结合动力学。通过体内多指示剂稀释技术记录了地高辛的跨肾小管转运;肾动脉注射奎尼丁不影响地高辛在肾静脉或尿液中的回收率。清除率研究表明,地高辛肾脏清除率的降低与肾血流量的显著下降平行,对氨基马尿酸清除率的降低证明了这一点。得出的结论是,奎尼丁抑制地高辛的肾脏排泄不是通过在肾小管细胞膜水平上的竞争,而是通过降低肾血流量。记录到地高辛胆汁清除率也有平行下降,这可能表明存在类似机制。